Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome
EFFORT2
1 other identifier
interventional
107
1 country
1
Brief Summary
Despite standard care, 25%-50% of patients with clots in the deep veins of the arms and legs progress to chronic post-clot problems resulting in significant disability, loss of productivity, and healthcare costs. Reverse flow in the veins from an organizing clot is the primary cause of post-clot problems. Veins with early clot breakdown have a lower incidence of reverse flow. The investigators have observed that clot breakdown is enhanced by increased blood flow and that moderate arm and leg exercise result in increased venous blood flow. Hence, the investigators predict that a supervised exercise program in patients with deep vein clots could increase leg vein blood flow, accelerate clot breakdown, and decrease the risk of post clot problems. The primary hypothesis is that increased blood flow across the clot (induced by supervised exercise) will increase clot breakdown and decrease severity of post clot problems. The investigators are conducting a randomized clinical trial of standard therapy compared to progressive exercise training in patients with leg deep vein clots.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2014
CompletedFirst Posted
Study publicly available on registry
May 28, 2014
CompletedStudy Start
First participant enrolled
September 15, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2021
CompletedResults Posted
Study results publicly available
October 23, 2024
CompletedOctober 23, 2024
October 1, 2024
7 years
May 21, 2014
February 15, 2024
October 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
2-year Change in Villalta Score
The Villalta score quantifies severity of symptoms and can be used to diagnose Post-Thrombotic Syndrome (PTS). The Villalta score quantifies severity of symptoms and can be used to diagnose Post-Thrombotic Syndrome (PTS). Higher Villalta scores denote more severe symptoms and greater likelihood of PTS. The outcome measure is not the score itself, but change in scores over time, calculated by subtracting the baseline score from the score at the 2-year follow-up. The range of the Villalta score is 0-33, so the minimum possible change is -33 and the maximum possible change is 33, with 0 indicating no change in Villalta scores (same score at baseline and at 2-year follow-up). An increase (positive change) in Villalta score indicates worsening symptoms, while a decrease (negative change) indicates improving symptoms.
Change from baseline to 2-year follow-up
2-year Change in VEINES-QOL Summary Score
The VEINES-QOL summary score is calculated from the Venous Insufficiency Epidemiological and Economic Study (VEINES) Quality of Life (QOL) questionnaire, and it provides an estimate of the overall impact of deep venous thrombosis (DVT) on the patient's quality of life. A higher VEINES-QOL score indicates better quality of life. The outcome measure is not the score itself, but change in scores over time, calculated by subtracting the baseline score from the score at the 2-year visit. The range of the VEINES-QOL summary score is 25-117, so the minimum possible change is -92 and the maximum possible change is 92, with 0 indicating no change in VEINES-QOL scores (same score at baseline and at 2-year follow-up). An increase (positive change) in VEINES-QOL score indicates an improvement in quality of life, and a decrease (negative change) indicates worsening quality of life.
Change from baseline to 2-year follow-up
Secondary Outcomes (2)
2-year Change in SF-36 Domain Scores
Change from baseline to 2-year follow-up
3-month Percent-change in Thrombus Volume
Change from baseline to 3-month follow-up
Study Arms (2)
Control
ACTIVE COMPARATORStandard care: anticoagulation, compression, and ad-lib ambulation
Exercise
EXPERIMENTALStandard care + Interventional Exercise therapy
Interventions
Eligibility Criteria
You may qualify if:
- Acute Lower Extremity DVT
- DVT documented by ultrasound, CT/Magnetic Resonance imaging (MR) venogram, or conventional venogram
- Enrolled within 4 weeks of onset of symptoms
- Age 18 years or older
You may not qualify if:
- Peripheral arterial disease (disabling claudication, rest pain, tissue loss) with ankle brachial index (ABI)\<0.5
- Immediate need for thrombolysis/thrombectomy
- DVT involving the inferior vena cava (IVC)
- Contraindication to anticoagulation
- Contraindications to exercise training
- Medical illness interfering with evaluation/follow-up
- Life expectancy \<2 years
- Pregnancy
- Inability to walk
- Hemodynamically significant PE
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VA Office of Research and Developmentlead
- University of Marylandcollaborator
Study Sites (1)
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, 21201, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Brajesh K. Lal
- Organization
- Veterans Administration of Baltimore Maryland
Study Officials
- PRINCIPAL INVESTIGATOR
Brajesh K Lal, MD
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2014
First Posted
May 28, 2014
Study Start
September 15, 2014
Primary Completion
August 31, 2021
Study Completion
August 31, 2021
Last Updated
October 23, 2024
Results First Posted
October 23, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share